(0593–0640) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster I

Sunday, October 26, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

Age at Diagnosis of SLE Has Increased in a United States Longitudinal Cohort
Abstract Poster Presenter: Daniel Goldman, PhD – Johns Hopkins University School of Medicine
10:30 AM - 12:30 PM Central Time

Assessment of the Metabolic Score for Insulin Resistance (METS-IR) and Its Associated Factors in Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Antonio Aznar-Esquivel, MD – Servicio Canario de Salud
10:30 AM - 12:30 PM Central Time

Association of Lifestyle and Integrative Health Practices with Health-related Quality of Life in Women with Systemic Lupus Erythematosus and Connective Tissue Disease
Abstract Poster Presenter: Sarah Lieber, MD, MS – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Association of Systemic Lupus Erythematosus with Healthcare Resource Utilization and Healthcare Expenditures: Analysis of Nationally Representative Data, 2017-2022
Abstract Poster Presenter: Ami Vyas, PhD – University of Rhode Island
10:30 AM - 12:30 PM Central Time

Cluster Analysis of Socioeconomic and Environmental Determinants Modifying Activity, Chronicity and Clinical Manifestations of Systemic Lupus Erythematosus in the GLADEL 2.0 Cohort
Abstract Poster Presenter: Marco Martinez, MD – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Comparative Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Patients with Systemic Lupus Erythematosus and Diabetes: A Propensity-Matched Retrospective Cohort Study
Abstract Poster Presenter: Rusudan Tskitishvili, MD – Virtua Health
10:30 AM - 12:30 PM Central Time

Comparison of the SARC-F with Objective Measures of Sarcopenia in Women with Systemic Lupus Erythematosus
Abstract Poster Presenter: Sarah Lieber, MD, MS – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Development, Validation and Performance of a Patient Knowledge Assessment Tool for Assessing the Immediate and Short-term Impact of an Information Course in Systemic Lupus Erythematosus
Abstract Poster Presenter: Ranjan Gupta, MD, DM (he/him/his) – All India Institute of Medical Sciences
10:30 AM - 12:30 PM Central Time

Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis (AAV) and Systemic Lupus Erythematosus (SLE): A Comparative Analysis
Abstract Poster Presenter: Sai Shanmukha Sreeram Pannala, MD (he/him/his) – Northwell Health/Staten Island University Hospital
10:30 AM - 12:30 PM Central Time

DNA Methylation Patterns Differ Between Genetically Similar Systemic Lupus Erythematosus (SLE) Patients From Peru and the U.S.
Abstract Poster Presenter: Sundus Dwidar, B.S. – National Institutes of Health
10:30 AM - 12:30 PM Central Time

DNA methylation patterns in systemic lupus erythematosus associated with nephritis status
Abstract Poster Presenter: Meghan Nelson, DO – National Institutes of Health
10:30 AM - 12:30 PM Central Time

Effect of Gender and Follow-up Time in Damage Accrual: Data from a Latin America Lupus Cohort
Abstract Poster Presenter: Guillermo Pons-Estel, MD, PhD – CREAR
10:30 AM - 12:30 PM Central Time

Efficacy of Statin Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease Among Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Aakash Patel, MD – Massachusetts General Hospital
10:30 AM - 12:30 PM Central Time

Evaluating Cardiovascular Risk in Systemic Lupus Erythematosus: Comparing Novel Risk Scores with Carotid Ultrasound
Abstract Poster Presenter: Ileana Cecilia Reynosa Silva, MD – Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
10:30 AM - 12:30 PM Central Time

Evaluation of Novel Anti-ATP1A1 Autoantibodies by ELISA to Predict Cardiac Neonatal Lupus (Cardiac-NL)
Abstract Poster Presenter: Nalani Sachan, PhD – NYU Grossman School of Medicine
10:30 AM - 12:30 PM Central Time

Genetic Risk Profiles Predict Clinical Heterogeneity in Systemic Lupus Erythematosus
Abstract Poster Presenter: Dag Leonard, MD, PhD – Uppsala University
10:30 AM - 12:30 PM Central Time

Α user-friendly machine-learning tool for early damage prediction in patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Panagiotis Garantziotis, MD – Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen
10:30 AM - 12:30 PM Central Time

Impact of Clinically Important Improvements in Patient-Reported Outcomes on Disease Activity in Patients With Systemic Lupus Erythematosus Treated With Upadacitinib or Placebo: Results From the Phase 2 SLEek Study
Abstract Poster Presenter: Vibeke Strand, MD, FACP, MACR – Stanford University School of Medicine, Palo Alto CA
10:30 AM - 12:30 PM Central Time

Increased Recombinant Zoster Vaccination in SLE following Public Reimbursement: Data from Two Prospective SLE Cohorts
Abstract Poster Presenter: Arielle Mendel, MD, FRCPC, MSc – McGill University Health Centre
10:30 AM - 12:30 PM Central Time

Interim Analysis of the Impact of a Recombinant Herpes Zoster Vaccine on Systemic Lupus Erythematosus: A Randomized Controlled Study on Immunogenicity, Safety and Immunosuppressor Effects
Abstract Poster Presenter: Luciana Seguro, MD, PhD – Hospital das Clínicas HCFMUSP, University of Sao Paulo
10:30 AM - 12:30 PM Central Time

Is Antimalarial Use Associated with a Reduced Risk of Lupus Nephritis in Patients with SLE? Results from an Inception Cohort-Based Study
Abstract Poster Presenter: Fadi Kharouf, MD – Hadassah Medical Center - Toronto Western Hospital
10:30 AM - 12:30 PM Central Time

Kidney Transplantation In Lupus Nephritis. Multicenter Study Of 103 Patients
Abstract Poster Presenter: Vanesa Calvo Río, MD – Hospital Universitario Marqués de Valdecilla, Immunopathology group, IDIVAL
10:30 AM - 12:30 PM Central Time

Marked Decline in SLE Mortality Despite Rising Mortality in the General Population During the COVID-19 Pandemic
Abstract Poster Presenter: Omer Pamuk, MD – University Hospitals Cleveland Medical Center/ Case Western Reserve University
10:30 AM - 12:30 PM Central Time

Neutropenia in SLE: a Retrospective Cohort Study of Etiologies, Severity, Management, and Infection Outcomes
Abstract Poster Presenter: Eleni Papachristodoulou, MD – Mount Auburn Hospital, Harvard Medical School
10:30 AM - 12:30 PM Central Time

Patients with SLE Have an Increased Bisphenol A Methylation Score Linked to SLE Risk Genes and Immune Response Pathways
Abstract Poster Presenter: Dag Leonard, MD, PhD – Uppsala University
10:30 AM - 12:30 PM Central Time

Polygenic risk of lupus is differentially associated with individual EHR-derived classification criteria
Abstract Poster Presenter: Matthew Dapas, PhD – Northwestern University
10:30 AM - 12:30 PM Central Time

Precipitants and Long-Term Outcomes of Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus: A Multicenter Cohort Study and Systematic Review
Abstract Poster Presenter: Ali Ardekani, MD, MSc – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Prevalence of lupus nephritis, end stage kidney disease, avascular necrosis, and mortality in systemic lupus erythematosus in the recent era
Abstract Poster Presenter: Takehiro Nakai, MD – St. Luke's International Hospital
10:30 AM - 12:30 PM Central Time

Risk Factors for Pulmonary Manifestations in GLADEL 2.0, a Systemic Lupus Erythematosus Latin American Cohort
Abstract Poster Presenter: LUIS CAJAS, Sr, MD, MSc – universidad nacional de colombia
10:30 AM - 12:30 PM Central Time

Shrinking Lung Syndrome in Systemic Lupus Erythematosus: A Pooled Database Analysis of Clinical, Immunological and Therapeutic Factors Impacting Outcomes
Abstract Poster Presenter: Malvika Gupta, MD (she/her/hers) – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Strong Correlation Between SLEDAI and SLE-DAS in the Spanish Population: Assessment of Discordant Patients
Abstract Poster Presenter: Elena Heras Recuero, MD – Hospital Fundacion Jimenez Dias
10:30 AM - 12:30 PM Central Time

Study of Long Term HCQ Safety on Cardiac Muscle Function in Patients with SLE and other Rheumatic Diseases
Abstract Poster Presenter: Nirali Sanghavi, MBBS – Westchester Medical Center
10:30 AM - 12:30 PM Central Time

Sustained Remission In SLE Is Infrequent On Standard Of Care: A Decade Of Insights From The Asia Pacific Lupus Collaboration
Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
10:30 AM - 12:30 PM Central Time

Systemic Lupus Erythematosus Flares in Patients with End-Stage Kidney Disease on Renal Replacement Therapy or after Transplant
Abstract Poster Presenter: Jacob Klein, MD – Ohio State University Wexner Medical Center
10:30 AM - 12:30 PM Central Time

The Role of Active Nephritis, Compared to Active Non-Renal SLE, in Pregnancy Outcomes
Abstract Poster Presenter: Emma Trachman, MD – Duke University
10:30 AM - 12:30 PM Central Time

The Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) Predicts Worsening Self-Efficacy in the Patients from the Almenara Lupus Cohort
Abstract Poster Presenter: Anubhav Singh, MD – Baptist hospital of southeast Texas
10:30 AM - 12:30 PM Central Time

The usefulness of neutrophil-to-lymphocyte ratio as a biomarker to predict lupus flares in patients under remission
Abstract Poster Presenter: Luis Fajardo Hermosillo, MD, MSc (he/him/his) – Universidad de Guadalajara RFC UGU250907MH5
10:30 AM - 12:30 PM Central Time

Therapeutic landscape of systemic lupus erythematosus pure membranous nephropathy: a nationwide population-based study
Abstract Poster Presenter: Kevin Chevalier – Université Paris Cité
10:30 AM - 12:30 PM Central Time

Toward a Consensus-Based Definition of Difficult-to-Treat Systemic Lupus Erythematosus: A Multinational Survey of Clinicians from the MENA Region
Abstract Poster Presenter: Ahlam Almarzooqi, MD – Emirates Health Services
10:30 AM - 12:30 PM Central Time

Transverse Myelitis in Systemic Lupus Erythematosus: Disease Manifestations and Clinical Outcomes from Multi-Center Data
Abstract Poster Presenter: Amir Daneshvar, MD – University Hospitals Cleveland Medical Center/Case Western Reserve University
10:30 AM - 12:30 PM Central Time

Venous Thromboembolism in Patients with Lupus Nephritis: Frequency and Risk Factors – A Cohort Study
Abstract Poster Presenter: Fadi Kharouf, MD – Hadassah Medical Center - Toronto Western Hospital
10:30 AM - 12:30 PM Central Time

A Baseline Kidney Biopsy Is Not Always Feasible in Incident Lupus Nephritis: Insights from an Inception Cohort
Abstract Poster Presenter: Fadi Kharouf, MD – Hadassah Medical Center - Toronto Western Hospital
10:30 AM - 12:30 PM Central Time

Neurofilament Light Chain Serum Levels is Associated with Neuropsychiatric Manifestations and Cognitive Dysfunction in Systemic Lupus Erythematosus Patients: A Longitudinal Study
Abstract Poster Presenter: Juliana Silvatti, MMSc (she/her/hers) – Universidade Federal de São Paulo
10:30 AM - 12:30 PM Central Time

AA Novel Kidney-specific Biomarker Panel Accurately Differentiates Lupus Nephritis from Diabetic Kidney Disease Through Distinct Molecular Pathways Novel Kidney-specific Biomarker Panel Accurately Differentiates Lupus Nephritis from Diabetic Kidney Disease Through Distinct Molecular Pathways
Abstract Poster Presenter: Sepehr Taghavi, MSc – Exagen Inc
10:30 AM - 12:30 PM Central Time

Antibodies to Type I and Type III Interferons at Diagnosis Predispose to Serious Infections on Follow up in an Inception Cohort of SLE (INSPIRE) from India
Abstract Poster Presenter: Rudrarpan Chatterjee, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
10:30 AM - 12:30 PM Central Time

Low 25-hydroxyvitamin D Levels are Associated with Higher Mortality and More Cardiovascular Events in Systemic Lupus Erythematosus
Abstract Poster Presenter: Michelle Petri, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine
10:30 AM - 12:30 PM Central Time

Autoantibodies to Extracellular Antigens in Lupus Patients Serum Versus Controls; Predominance of Autoantibodies to Type I Interferons in Lupus Sera
Abstract Poster Presenter: Kathryn Counts, BS (she/her/hers) – Medical University of South Carolina
10:30 AM - 12:30 PM Central Time

Characterizing Arthritis Subtypes in SLE: Prevalence, Clinical Features, and the Role of Type I Interferon Signatures
Abstract Poster Presenter: Pankti Mehta, MD, MBBS, DM – University of Toronto